about us

We are a bioinformatics and multi-omics company

We are driven forward by a vision of a future where cancer is curable.

Work with us


UDX has an international team of  scientists, researchers, clinical managers and tech entrepreneurs inspired by its mission to create a future where cancer is curable.

Juan Martínez Barea
Founder and Executive President

Juan is a successful tech entrepreneur who has launched more than 100 start-ups, including the first high-tech start-up accelerator in Southern Europe. He received an MBA from the Massachusetts Institute of Technology (MIT), an M.S. in Economics from Ecole Centrale in Paris, and M.S. and B.S. in Industrial Engineering from Universidad de Sevilla. He was selected as an Endeavor Entrepreneur in 2021.

Antonio Carro
Chief Executive Officer

Antonio brings more than 25 years of experience launching and leading new technology companies, including one publicly-traded on the NASDAQ. In addition to his experience as an entrepreneur and chief executive, he spent 8 years at McKinsey & Co where he leaded the EU Telco practice. He received an MBA from the Institut Europeen d’Administration des Affaires (INSEAD).

Christian Hense
Chief Operating Officer

Christian brings more than 15 years of experience in Life Sciences to his role. Formerly, he was a member of Boston Consulting Group’s Operations and Healthcare team and led the company’s recruiting efforts. He received an MBA from the Institut Europeen d’Administration des Affaires (INSEAD), and is a member of Handelsblatt Health Circle and was selected as Endeavor Entrepreneur in 2021.

Kristi Kruusmaa
Chief Scientific Officer

Kristi brings more than 10 years of experience in biotechnology to her role. Her areas of expertise and study include genetics, cancer biology, liquid biopsy, method development and data analysis. At Universal DX, she is leading a multidisciplinary team in diagnostic product development focusing on GI tract cancers. She received a B.S. in Genetics and a M.S. in Biotechnology & Biochemistry from Tallinn University of Technology.

Ignacio López-Bravo
Chief Financial Officer

Ignacio brings more than 10 years of experience in financial services and management consulting to his role. Formerly, he held roles at global financial consulting firms Barclays Capital, PwC and Kearney. He received a B.S. in Business Administration from ICADE (Madrid) and HEC Montreal, an MBA from the Institut Europeen d’Administration des Affaires (INSEAD). He was selected at Singularity University’s Global Startup Program 2019 with UDX.

Álvaro Leiva
Chief Administrative Officer

Alvaro brings more than 10 years of experience in management consulting, with a focus on advising tech start-ups. He received an MBA from San Telmo Business School and also completed The Executive Program on Entrepreneurship at MIT. He received a B.A. in Business Administration from the University of North Florida.

Scientific Advisors

Dr. Renee L. Williams
Associate Professor, Department of Medicine, NYU Langone, New York, US

Co-Chair of the New York Citywide Colorectal Cancer Control Coalition risk assessment and screening committee. Former chair of the Diversity, Equity, and Inclusion Committee for the American College of Gastroenterology (ACG).

Dr. Samir Gupta
Associate Professor at the University of California, San Diego, California, US

Former vice chair of the National Comprehensive Cancer Network guideline committees for genetic/high-risk familial assessment and screening for colorectal cancer.

Dr. Uri Ladabaum
Stanford University, Palo Alto, US

Head of Colorectal Cancer Screening Program

David Lieberman
Oregon Health & Science University, Oregón, Portland, US

Professor of Medicine, Chief Division of Gastroenterology

Aasma Shaukat
NYU Grossman School of Medicine, New York City, US

Physician and clinical researcher. Director of Gastroenterology outcomes Research and co-director of translational research education and careers in the Clinical and Translational Science Institute.

Dr. Michael Roehrl
Chief of the Department of Pathology at BIDMC, Boston, Massachusetts, US

Chief of the Department of Pathology at the Beth Israel Deaconess Medical Center (BIDMC); Specialized in diagnosing gastrointestinal diseases such as colorectal and pancreatic cancers.

Dr. Toni Castells
Clinic Hospital, Barcelona, Spain

Medical Director. Head of Colorectal Cander Screening Program.

Dr. Josep Tabernero
Vall d´Hebron Hospital, Barcelona, Spain

Director of the Institute of Oncology, ESMO President.

Dr. Thomas Rösch
Gastroenterologist, Hamburg, DE

Medical Director. Center for Endoscopy UKE Hamburg; Member of Global Clinical Trial Board Epigenomics

Dr. Siegbert Faiss
Gastroenterologist, Berlin, DE

Medical Director. Gastroenterology of Sana Klinikum Lichtenberg, Site Principal Investigator Germany; Member of Global Clinical Trial Board Epigenomics.

Dr. James Kinross
Colorectal Cancer Surgeon, London, UK

Colorectal Surgeon and Clinical Senior Lecturer in Colorectal Surgery. Member of Faculty of Medicine, Department of Surgery & Cancer at Imperial College London.

Our Partners

Clinical Partners





We have built a network of >100 hospitals in the U.S. and across Europe with whom we have recruited >12K samples and work with more than hundred gastrointestinal clinical teams. We are currently running an observational study, USOPTIVAL, for which we are recruiting 1,200 patients at >15 US hospitals.



Work With Us

UDX is developing a Cancer Platform, a set of minimally-invasive, blood-based solutions for detecting cancer early when treatment-options are more plentiful. Wanna be part of this?

View open positions